Clinical Trials Logo

Common Bile Duct Stones clinical trials

View clinical trials related to Common Bile Duct Stones.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02144493 Recruiting - Clinical trials for Common Bile Duct Stones

Risk Factors for Recurrence of Primary Bile Duct Stones

Start date: May 2014
Phase: N/A
Study type: Observational

Recurrent common bile duct stone is one of the risk factors of recurrent cholangitis. However, the exact pathophysiology or mechanism of recurrent cholangitis has not been established. Periampullary diverticulum and narrow angle of common bile duct have been postulated as risk factors of recurrent common bile duct stone. The aim of this study was to evaluate the association between periampullary dierticulum, angle of common bile duct and recurrent common bile duct stone.

NCT ID: NCT01829139 Recruiting - Clinical trials for Common Bile Duct Stones

Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones

Start date: March 2012
Phase: N/A
Study type: Observational [Patient Registry]

In patients with gallbladder in situ after complete removal of common bile duct (CBD) stones, there is no definite guideline for the management of remnant acalculous gallbladder. This study was planned to evaluate the efficacy of choleretic agents in those patients comparing with non-treatment group during short (2 years) and long-term (5 to 10 years) period. So that, the investigators want to establish the treatment guideline in gallbladder in situ without definite stones following complete removal of CBD stones. Second, the protective or preventive effect of choleretics may be defined.